Results of the Spanish Farma-Biotech Cooperation Program

4 July 2015

Last week saw the presentation of the Farma-Biotech Cooperation Program report, fostered by the pharma trade group Farmaindustria.

This report features the most important landmarks of this initiative during the period 2011 (when it was initiated) and 2014. Thus, it is worth highlighting that, during the 12 meetings celebrated within the framework of the Program, more than 93 stakeholders have participated, generating 86 projects of interest, said Farmaindustria.

The Farma-Biotech Cooperation Program was born in 2011 in the framework of the Spanish Technological Platform for Innovative Medicines with the aim of facilitating the necessary information and fostering potential cooperation agreements between pharmaceutical companies, Spanish small biotechnological enterprises and research centers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology